// App-Quantinova.ai

: SUBGROUP ANALYSIS IN THE GLOBAL SYMPLICITY REGISTRY ( 3-YEAR SAFETY AND EFFICACY )

Researchers

Presenter

  • Mahfoud, F

Principal Investigators

  • Mancia, G

  • Schmieder, R

  • Narkiewicz, K

  • Ruilope, L

  • Schlaich, M

  • Williams, B

  • Fahy, M

  • Bhm, M

Medical Centers

  • Saarland University Hospitals, Homburg/Saar, Germany

  • University of Milano-Bicocca, Monza, Italy

  • University Hospital Erlangen, Erlangen, GERMANY

  • Medical University of Gdansk, Gdansk, Poland

  • Hospital Universitario Doce de Octubre, Madrid, Spain

  • Dobney Hypertension Center, Perth, AUSTRALIA

  • Medicine, Imperial College London, London, UNITED KINGDOM

  • Medtronic, PLC, Santa Rosa, CA, USA

Locations

  • Germany

  • Italy

  • Poland

  • Spain

  • Australia

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

  • Central Nervous System (CNS)

Disease

  • Type 2 diabetes mellitus

  • Sleep apnoea

  • Diabetes

  • Hypertension

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved